Oorsprong van het eerstegraads netwerk van Stuart Wynn Hughes
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Pathios Therapeutics Ltd.
Pathios Therapeutics Ltd. BiotechnologyHealth Technology Pathios Therapeutics Ltd. engages in discovering and developing novel small molecule drugs. The company was founded by Thomas David McCarthy, Alan Naylor, Kirsty McCarthy, Peter Joyce and Someit Sidhu in 2017 and is headquartered in Oxford, the United Kingdom.
7
| Holding Company | Biotechnology | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Stuart Wynn Hughes via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Grey Wolf Therapeutics Ltd.
Grey Wolf Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Grey Wolf Therapeutics Ltd. is a biotechnology company, which engages in the drug discovery in immuno-oncology. It targets endoplasmic reticulum aminopeptidases 1 and 2 in the antigen presentation pathway to drive modulation of the neoantigen repertoire on tumour cells. The company was founded by Thomas D. McCarthy and Peter Joyce and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Founder Founder Chief Operating Officer | |
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Investment Managers | Chief Executive Officer Private Equity Investor Consultant / Advisor | |
Canaan Management, Inc.
Canaan Management, Inc. Investment ManagersFinance Canaan Management, Inc. (Canaan Management) is a venture capital firm founded in 1987 by Eric A. Young. The firm is headquartered in Westport, CT. | Investment Managers | Private Equity Investor | |
BioMelbourne Network | Corporate Officer/Principal | ||
HARPOON THERAPEUTICS, INC. | Biotechnology | Founder | |
Hatchtech Pty Ltd.
Hatchtech Pty Ltd. Pharmaceuticals: MajorHealth Technology Hatchtech Pty Ltd. operates as pharmaceutical product company. It offers Xeglyze lotion that is head lice treatment. The company was founded by Vernon Morrison Bowles in 2001 and is headquartered in in Melbourne, Australia. | Pharmaceuticals: Major | Director/Board Member | |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Doctorate Degree | |
Fibrotech Therapeutics Pty Ltd.
Fibrotech Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Fibrotech Therapeutics Pty Ltd develops novel drug candidates for the treatment of the fibrosis prevalent in such chronic conditions as kidney disease, chronic heart failure, pulmonary fibrosis, and arthritis. The company was founded by Richard Ernest Gilbert, Darren James Kelly, Spencer J Williams, Steven C Zammit, David Stapleton, Henry Krum and Yuan Zhang in 2006 and is headquartered in Melbourne, Australia. | Pharmaceuticals: Major | Chairman | |
OSPY MEDI CDI | Medical Specialties | Director/Board Member | |
PolyActiva Pty Ltd.
PolyActiva Pty Ltd. BiotechnologyHealth Technology PolyActiva Pty Ltd. develops drug-polymer conjugate technology. Its platform technology is used to make plastic components for medical devices from drugs and manufacture process is novel and provides greater flexibility over the composition of the final material and better product outcomes compared with competitor technologies. The firm has built drug-polymer conjugates from a number of drug candidates with different chemical structures and linkage points, demonstrating the plasticity of the technology and developed a number of functional co-monomers and polymer segments, which modularises the production of the final conjugate. The company was founded in February 2010 and is headquartered in Melbourne, Australia. | Biotechnology | Chairman | |
Global Kinetics Pty Ltd.
Global Kinetics Pty Ltd. Medical SpecialtiesHealth Technology Global Kinetics Pty Ltd. provides point of care measurement and reporting of Parkinson's disease motor symptoms. Its product includes Personal KinetiGraph (PKG), a wrist worn medical device which reminds the patient when they have taken Levodopa medication as prescribed by doctor. The company was founded by Robert Griffiths and Malcolm Horne in 2007 and is headquartered in Melbourne, Australia. | Medical Specialties | Director/Board Member | |
BACE Therapeutics Pty Ltd. | Director/Board Member | ||
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
OccuRx Pty Ltd
OccuRx Pty Ltd BiotechnologyHealth Technology OccuRx Pty Ltd provides biopharmaceutical services. It engages in the development of therapeutic strategies for the treatment of ophthalmic disorders associated with retinal fibrosis and inflammation. The company was founded by Darren J. Kelly in 2014 and is headquartered in Melbourne, Australia. | Biotechnology | Chairman | |
Otifex Therapeutics Pty Ltd.
Otifex Therapeutics Pty Ltd. Medical SpecialtiesHealth Technology Otifex Therapeutics Pty Ltd. develops treatment for ear diseases. The company was founded by Burkhard Franz and Colin Anderson in 2009 and is headquartered in Melbourne, Australia. | Medical Specialties | Director/Board Member | |
University of Pennsylvania | College/University | Masters Business Admin | |
Baker Heart & Diabetes Institute
Baker Heart & Diabetes Institute Miscellaneous Commercial ServicesCommercial Services Baker Heart & Diabetes Institute owns and operates a medical research institute. The company is headquartered in Melbourne, Australia. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Azura Ophthalmics Pty Ltd.
Azura Ophthalmics Pty Ltd. Medical SpecialtiesHealth Technology Azura Ophthalmics Ltd. develops therapies for meibomian gland dysfunction. It offers a portfolio of compounds in combination with a novel drug delivery platform to advance a portfolio of treatments for meibomian gland dysfunction. The company was founded by Yair Alster in 1980 and is headquartered in Tel Aviv, Israel. | Medical Specialties | Director/Board Member | |
Cardiora Pty Ltd.
Cardiora Pty Ltd. Investment Trusts/Mutual FundsMiscellaneous Cardiora Pty Ltd. functions as a clinical stage pharmaceutical company. It develops CRD-102, an oral medicine for heart failure. The company was founded by David Kaye in 2015 and is headquartered in Melbourne, Australia. | Investment Trusts/Mutual Funds | Director/Board Member | |
EBR SYSTEMS, INC. | Medical Specialties | Director/Board Member | |
Athena Medicines Pty Ltd. | Director/Board Member | ||
QUE Oncology, Inc.
QUE Oncology, Inc. Pharmaceuticals: MajorHealth Technology QUE Oncology, Inc. engages in preventing and treating life-threatening cancers such as prostate cancer, breast cancer, melanoma, and cancer pain; and related conditions. The company is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Director/Board Member | |
Medical Research Commercialisation Fund Trust
Medical Research Commercialisation Fund Trust Investment ManagersFinance Medical Research Commercialisation Fund Trust invests in life science companies located in Australia. The fund focuses on companies operating in the fields of medical research institutes and allied research hospitals. It provides seed and early stage financing in project investment of up to $0.02 million, at the stage of company formation invests up to $4 million and also makes follow-on investments of up to $2 million. It seeks co-investment with other investors for technologies with larger capital requirements. | Investment Managers | Chief Executive Officer | |
Australian Investment Council
Australian Investment Council Miscellaneous Commercial ServicesCommercial Services Australian Investment Council is an Australian private company located in Sydney. The firm operates as an association. Navleen Prasad has been the CEO since 2022. | Miscellaneous Commercial Services | Director/Board Member | |
Certa Therapeutics Pty Ltd.
Certa Therapeutics Pty Ltd. BiotechnologyHealth Technology Certa Therapeutics Pty Ltd. operates as biotechnology company. The firm develops drugs for treatment for kidney disease. The company was founded by Darren James Kelly and is headquartered in Melbourne, Australia. | Biotechnology | Director/Board Member | |
STARPHARMA HOLDINGS LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
Monash University
Monash University Other Consumer ServicesConsumer Services Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia. | College/University | Undergraduate Degree | |
Orbit Discovery Ltd.
Orbit Discovery Ltd. Pharmaceuticals: MajorHealth Technology Orbit Discovery Ltd. develops technology for discovery process and drug development. The company was founded by Terry Rabbitts and Graham Ogg and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Amphivena Therapeutics, Inc.
Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | Drugstore Chains | Chief Executive Officer | |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer | |
The University of California, San Francisco | College/University | Doctorate Degree | |
Ethicon Endo-Surgery, Inc.
Ethicon Endo-Surgery, Inc. Medical SpecialtiesHealth Technology Ethicon Endo-Surgery, Inc. manufactures surgical devices and equipments. Its products include the ENDOPATH XCEL access system, CONTOUR curved cutter stapler, HARMONIC ultrasonic cutting and coagulation surgical devices and the MAMMOTOME breast biopsy system. The company was founded in 1992 and is headquartered in Cincinnati, OH. | Medical Specialties | Corporate Officer/Principal | |
EndoGastric Solutions, Inc.
EndoGastric Solutions, Inc. Medical SpecialtiesHealth Technology EndoGastric Solutions, Inc. develops natural orifice surgical products and procedures to advance the treatment of gastrointestinal diseases. The firm offers EsophyX device and StomaphyX device. The company was founded by Stefan J. M. Kraemer, Clifton A. Alferness, Scott Jordan Wolf, James W. Fitzsimmons and John M. Adams in 2003 and is headquartered in Redmond City, WA. | Medical Specialties | Director/Board Member | |
Relievant Medsystems, Inc.
Relievant Medsystems, Inc. Medical SpecialtiesHealth Technology Relievant Medsystems, Inc. develops treatment and technologies for chronic back pain. Its Intracept System solution is a minimally invasive procedure that uses radiofrequency energy delivered into the vertebral body of the spine to ablate the basivertebral nerve. Relievant Medsystems was founded by James C. Peacock, Jeffrey Charles Lotz, and Rex Peters in 2004 and is headquartered in Redwood City, CA. | Medical Specialties | Director/Board Member | |
University of Dayton | College/University | Graduate Degree | |
Minimally Invasive Devices, Inc.
Minimally Invasive Devices, Inc. Medical SpecialtiesHealth Technology Minimally Invasive Devices, Inc. develops laparoscopic visualization tools and systems. It offers FloShield Air, a vortex barrier technology that provides a continuous flow of dry carbon dioxide gas over the tip of the scope, instantly defogging it while continuously shielding it from condensation, debris, and smoke. It also offers FloShield Plus, an intra-operative flush that can be used to clean a scope if it gets dirty during surgery. The company was founded by Wayne L. Poll and Jodi Wolfe in 2006 and is headquartered in Columbus, OH. | Medical Specialties | Director/Board Member | |
Tuck School of Business at Dartmouth | College/University | Masters Business Admin | |
Data Sciences International, Inc.
Data Sciences International, Inc. BiotechnologyHealth Technology Data Sciences International, Inc. offers telemetry instrumentation and software and services in support of research. Its services include data services, surgical services, validation services and technical training. The firm’s products include implantable and external telemetry, software, signal conditioners, glucose monitoring, infusion pumps and inhalation/exposure systems. The company was founded by Brian P. Brockway in 1984 and is headquartered in St. Paul, MN. | Biotechnology | Director/Board Member | |
Semnur Pharmaceuticals, Inc.
Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Director/Board Member | |
Coapt Systems, Inc.
Coapt Systems, Inc. BiotechnologyHealth Technology Coapt Systems, Inc. designs, develops, manufactures and markets bio absorbable implants for surgeons to use in plastic surgery to fixate soft tissue to other soft tissue and bone. The company was founded in 2000 and is headquartered in Palo Alto, CA. | Biotechnology | Director/Board Member | |
Novare Surgical Systems, Inc.
Novare Surgical Systems, Inc. Medical SpecialtiesHealth Technology Novare Surgical Systems, Inc. manufactures and supplies surgical equipment. Its products include laparoscopic, surgical, electrosurgical instruments, surgical laser and clamps, skin markers and orthopedic appliances. The company was founded by Thomas J. Fogarty and Kerry Pope in 1999 and is headquartered in Cupertino, CA. | Medical Specialties | Director/Board Member | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
Unchained Labs
Unchained Labs BiotechnologyHealth Technology Unchained Labs designs, develops, and manufactures tools and devices for biologics research. It sells its products to biopharma and academic customers. The company was founded by Timothy A. Harkness in January 2015 and is headquartered in Pleasanton, CA. | Biotechnology | Director/Board Member | |
ITERUM THERAPEUTICS PLC | Pharmaceuticals: Major | Chairman |
Statistieken
Internationaal
Verenigde Staten | 26 |
Australië | 22 |
Verenigd Koninkrijk | 3 |
Israël | 2 |
Ierland | 2 |
Sectoraal
Health Technology | 30 |
Consumer Services | 7 |
Finance | 5 |
Commercial Services | 4 |
Health Services | 3 |
Operationeel
Director/Board Member | 42 |
Corporate Officer/Principal | 13 |
Founder | 8 |
Chairman | 7 |
Chief Executive Officer | 5 |
Sterkste connecties
Insiders | |
---|---|
Brent Ahrens | 30 |
Chris Nave | 24 |
Jeanmarie Guenot | 7 |
Thomas Mccarthy | 7 |
Alan Naylor | 3 |
Peter Joyce | 2 |
Kirsty McCarthy | 2 |
- Beurs
- Insiders
- Stuart Wynn Hughes
- Bedrijfsconnecties